Intervet appoints Jochen Bader Vice President Finance and Control
15 November 2006
Intervet, the animal health business unit of Akzo Nobel, appointed the current Director Finance and Control, Jochen Bader (46), Vice President Finance and Control.
After graduating from ‘Fachhochschule’ (University of Applied Sciences) in Business Administration in Landshut (Germany), Jochen Bader joined the corporate finance department of Hoechst Roussel Vet (HR Vet) in 1987. Following a two year assignment with HRVet South Africa, he became financial controller with HRVet UK in 1995. After the acquisition of HR Vet by Intervet in 1999 he held General Manager positions in India and Taiwan and was promoted to Director Finance and Control of Intervet in Boxmeer, The Netherlands in 2003.
Ruurd Stolp, President, Intervet, said: “With the broad experience in commercial and financial management functions, Jochen Bader has the right qualifications and capabilities that uniquely position him to lead the finance and controlling discipline within Intervet.”
- end -
Note for the editor
Intervet, a business unit of Akzo Nobel, based in Boxmeer, the Netherlands, with sales of EUR 1,094 million in 2005, is dedicated to research and development, production and marketing of innovative animal health products. Intervet's product range for use in livestock, companion animals, poultry and fish includes vaccines, antiparasitics, anti-infectives, endocrine products and other pharmaceutical specialties. Intervet operates globally with its own marketing organizations. The company currently employs around 5,000 people.
Internet: www.intervet.com
Akzo Nobel is a Global Fortune 500 company and is listed on both the Euronext Amsterdam and NASDAQ stock exchanges. It is also included on the Dow Jones Sustainability Indexes and FTSE4Good Index. Based in the Netherlands, we are a multicultural organization serving customers throughout the world with human and animal healthcare products, coatings, and chemicals. We employ more than 62,000 people and conduct our activities in four segments − human and animal health, coatings and chemicals − subdivided into 13 business units, with operating subsidiaries in more than 80 countries. Consolidated revenues for 2005 totaled EUR 13.0 billion. The financial results for the full year will be published on February 15, 2007.
Internet: www.akzonobel.com
Not for publication – for more information
Suzanne Hendriksen Tel: +31 (0)485 58 7893
Media Relations Officer Fax: +31 (0)485 58 5392
Intervet International bv suzanne.hendriksen@intervet.com
